ATOSSA THERAPEUTICS, INC. Preferred Stock Dividends, Income Statement Impact
ATOSSA THERAPEUTICS, INC. (ATOS) reported Preferred Stock Dividends, Income Statement Impact of $11.48 million for the 3-month period ending 2018-06-30, per its 10-Q/A filed 2018-11-13.
Discontinued › Expense Statement › Operating Expenses
us-gaap:PreferredStockDividendsIncomeStatementImpact · last filed 2018-11-13
- ATOSSA THERAPEUTICS, INC. preferred stock dividends, income statement impact for the quarter ending 2018-06-30 was $11.48M, a 346.99% increase year-over-year.
- ATOSSA THERAPEUTICS, INC. preferred stock dividends, income statement impact for the quarter ending 2017-12-31 was $0.00.
- ATOSSA THERAPEUTICS, INC. preferred stock dividends, income statement impact for the quarter ending 2017-09-30 was $0.00.
- ATOSSA THERAPEUTICS, INC. preferred stock dividends, income statement impact for the quarter ending 2017-06-30 was $2.57M.
- ATOSSA THERAPEUTICS, INC. preferred stock dividends, income statement impact for fiscal 2017 was $2.57M.
| Period end | Preferred Stock Dividends, Income Statement Impact 3 month | Preferred Stock Dividends, Income Statement Impact 3 month as first filed | Preferred Stock Dividends, Income Statement Impact 6 month | Preferred Stock Dividends, Income Statement Impact 6 month as first filed | Preferred Stock Dividends, Income Statement Impact 9 month | Preferred Stock Dividends, Income Statement Impact 12 month |
|---|---|---|---|---|---|---|
| 2018-06-30 | $11.48M 10-Q/A · filed 2018-11-13 | $4.78M 10-Q · filed 2018-08-13 | $11.48M 10-Q/A · filed 2018-11-13 | $4.78M 10-Q · filed 2018-08-13 | ||
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-08 | $0.00 derived: sum of 2 quarters · filed 2018-03-08 | $2.57M derived: sum of 3 quarters · filed 2018-11-13 | $2.57M 10-K · filed 2018-03-08 | ||
| 2017-09-30 | $0.00 derived: 10-Q 9 month − 10-Q/A 6 month · filed 2017-11-13 | $2.57M derived: sum of 2 quarters · filed 2018-11-13 | $2.57M 10-Q · filed 2017-11-13 | |||
| 2017-06-30 | $2.57M 10-Q/A · filed 2018-11-13 | $2.57M 10-Q/A · filed 2018-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| ARTELO BIOSCIENCES, INC. (ARTL) | United States | $0.023B | |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |